DrugPatentWatch Database Preview
Drugs in Development Information for Fluoropyrimidine
Email this page to a colleague
See Plans and PricingWhat is the drug development status for Fluoropyrimidine?
Fluoropyrimidine is an investigational drug.
There have been 227 clinical trials for Fluoropyrimidine.
The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2016.
The most common disease conditions in clinical trials are Colorectal Neoplasms, Stomach Neoplasms, and Adenocarcinoma. The leading clinical trial sponsors are National Cancer Institute (NCI), Hoffmann-La Roche, and Eli Lilly and Company.
There are eighty-six US patents protecting this investigational drug and one international patent.
Summary for Fluoropyrimidine
| US Patents | 86 |
| International Patents | 1,153 |
| US Patent Applications | 0 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2016-09-01) |
| Vendors | 61 |
Recent Clinical Trials for Fluoropyrimidine
| Title | Sponsor | Phase |
|---|---|---|
| A Trial to Evaluate the Potential Benefit of Adjuvant Chemotherapy for Small Bowel Adenocarcinoma | Cancer Research UK | Phase 3 |
| A Trial to Evaluate the Potential Benefit of Adjuvant Chemotherapy for Small Bowel Adenocarcinoma | Kom Op Tegen Kanker | Phase 3 |
| A Trial to Evaluate the Potential Benefit of Adjuvant Chemotherapy for Small Bowel Adenocarcinoma | Belgian Group of Digestive Oncology | Phase 3 |
Clinical Trial Summary for Fluoropyrimidine
Top disease conditions for Fluoropyrimidine
Top clinical trial sponsors for Fluoropyrimidine
US Patents for Fluoropyrimidine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Fluoropyrimidine | Start Trial | Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators | JANSSEN PHARMACEUTICA NV (Beerse, BE) | Start Trial |
| Fluoropyrimidine | Start Trial | Combination chemotherapy comprising a liposomal prodrug of mitomycin C | Lipomedix Pharmaceuticals Ltd. (Jerusalem, IL) Shaare Zedek Scientific Ltd. (Jerusalem, IL) | Start Trial |
| Fluoropyrimidine | Start Trial | Bioactive substance in a barbed suture | Covidien LP (Mansfield, MA) | Start Trial |
| Fluoropyrimidine | Start Trial | Combination therapy with an anti-hyaluronan agent and therapeutic agent | Halozyme, Inc. (San Diego, CA) | Start Trial |
| Fluoropyrimidine | Start Trial | Cell-specific internalizing RNA aptamers against human CCR5 and uses therefore | City of Hope (Duarte, CA) The Scripps Research Institute (La Jolla, CA) | Start Trial |
| Fluoropyrimidine | Start Trial | Non-aqueous electrolyte and lithium secondary battery comprising same | LG Chem, Ltd. (KR) | Start Trial |
| Fluoropyrimidine | Start Trial | Substituted reverse pyrimidine Bmi-1 inhibitors | PTC THERAPEUTICS, INC. (South Plainfield, NJ) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Fluoropyrimidine
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Fluoropyrimidine | Australia | 2017217542 | 2036-02-10 | Start Trial |
| Fluoropyrimidine | Brazil | 112018016329 | 2036-02-10 | Start Trial |
| Fluoropyrimidine | Canada | 3014314 | 2036-02-10 | Start Trial |
| Fluoropyrimidine | China | 109071488 | 2036-02-10 | Start Trial |
| Fluoropyrimidine | Eurasian Patent Organization | 201891799 | 2036-02-10 | Start Trial |
| Fluoropyrimidine | European Patent Office | 3414233 | 2036-02-10 | Start Trial |
| Fluoropyrimidine | Israel | 261046 | 2036-02-10 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
